Sumi Das is a associate at CapitalG, Alphabet’s unbiased development fund, the place he leads healthcare tech and shopper fintech investments. Prior investments embrace Robinhood, Stripe, Convoy, Albert, Aye Finance, Subsequent Insurance coverage and Attempt Well being.
Nina Gerson is a vp at CapitalG, Alphabet’s unbiased development fund, the place she co-leads healthcare tech investments. Prior investments embrace Attempt Well being and Subsequent Insurance coverage.
The pandemic has highlighted among the brightest spots — and best areas of want — in America’s healthcare system. On one hand, we’ve witnessed the vibrancy of America’s innovation engine, with notable contributions by U.S.-based scientists and corporations for vaccines and coverings.
Alternatively, the pandemic has highlighted each the distribution challenges and value inefficiencies of the healthcare system, which now accounts for almost a fifth of our GDP — way over another nation — but lags many different developed nations in scientific outcomes.
Many of those challenges stem from an absence of alignment between fee and incentive fashions, in addition to an overreliance on hospitals as facilities for care supply. A 3rd of healthcare prices are incurred at hospitals, although at-home fashions will be simpler and reasonably priced. Moreover, most suppliers depend on charge for service as a substitute of preventive care preparations.
These elements mix to make care on this nation reactive, transactional and inefficient. We are able to enhance each outcomes and prices by shifting care from the hospital again to the place it began — at house.
Proper now in-home care accounts for under 3% of the healthcare market. We predict that it’s going to develop to 10% or extra inside the subsequent decade.
In-home care is nothing new. Within the Nineteen Thirties, over 40% of physician-patient encounters came about within the house, however by the Nineteen Eighties, that determine dropped to beneath 1%, pushed by modifications in well being economics and applied sciences that led to immediately’s hospital-dominant mannequin of care.
That fifty-year shift consolidated prices, centralized entry to specialised diagnostics and coverings, and created facilities of excellence. It additionally created a transition from proactive to reactive care, eliminating the longitudinal relationship between affected person and supplier. In immediately’s system, sufferers are sometimes identified by and obtain therapy from particular person docs who don’t seek the advice of each other. These extremely siloed remedies usually happen solely after the affected person wants emergency care. This creates increased prices — and worse outcomes.
That’s the place in-home care may help. Proper now in-home care accounts for solely 3% of the healthcare market. We predict that it’s going to develop to 10% or extra inside the subsequent decade. This development will enhance the affected person expertise, obtain higher scientific outcomes and cut back healthcare prices.
To make these enhancements, in-home healthcare methods might want to leverage next-generation expertise and value-based care methods. Luckily, the window of alternative for change is open proper now.
5 elements driving the chance for change
Over the previous couple of years, 5 important improvements have created new incentives to drive dramatic modifications in the best way care is delivered.
- Applied sciences like distant affected person monitoring (RPM) and telemedicine have matured to some extent that may be deployed at scale. These applied sciences allow suppliers to remotely handle sufferers in a proactive, long-term relationship from the consolation of their houses and at a decreased price.